Modafinil vs bromantane

Modafinil (A-tier) vs bromantane (B-tier). mechanism, trials, evidence boundaries, dosing literature. side-by-side reference.

Modafinil · tier A

Modafinil is an oral Schedule IV wake-promoting drug approved for excessive sleepiness associated with narcolepsy, obstructive sleep apnea, and shift-work disorder. Those indications do not establish broad cognitive enhancement in rested healthy people.

Modafinil improves wakefulness in defined sleep disorders. A small severe sleep-deprivation experiment found task-specific effects, but sleep deprivation is not rested-user evidence and does not establish broad cognition, productivity, mood, or long-term safety claims.

3 approved excessive-sleepiness settings · half-life about 15 h for oral modafinil in the label PK record · focus

bromantane · tier B

a Russian antiasthenic CNS drug with older human studies in illness-related fatigue, incomplete modern replication, no traceable primary human half-life source, and in-competition WADA prohibition.

bromantane has a real Russian drug and human-study record for asthenia, but that record does not establish healthy cognitive enhancement, long-term safety, or the internet's preferred half-life number.

728 patients in the largest indexed Russian asthenia study · half-life not structured; the repeated 11.21-hour human claim was not traced to an accessible primary PK source · focus

at a glance

• Modafinil: tier A · 3 approved excessive-sleepiness settings
• bromantane: tier B · 728 patients in the largest indexed Russian asthenia study

reptides grades the research record and cites the literature behind every call. research reference only; not medical advice.